Power Corp of Canada’s Regeneron Pharmaceuticals REGN Stock Holding History

Power Corp of Canada’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-6,078	Closed	-$5.34M	–	129
2023 Q4	$5.34M	Sell	6,078 -1,591	-21%	-$1.31M	0.55%	61
2023 Q3	$6.31M	Hold	7,669	–	–	0.4%	41
2023 Q2	$5.51M	Hold	7,669	–	–	0.55%	51
2023 Q1	$6.29M	Buy	7,669 +4,209	+122%	+$3.17M	0.65%	35
2022 Q4	$2.5M	Hold	3,460	–	–	0.45%	52
2022 Q3	$2.38M	Hold	3,460	–	–	0.56%	50
2022 Q2	$2.04M	Buy	3,460 +760	+28%	+$494K	0.41%	34
2022 Q1	$1.89M	Buy	+2,700	New	+$1.71M	0.16%	90

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Power Corp of Canada's REGN Position: Q1 2024 in Review

Power Corp of Canada sold out of Regeneron Pharmaceuticals (REGN) in Q1 2024, closing a stake of 6,078 shares — an estimated $5.34M sold.

Power Corp of Canada first reported a position in REGN in Q1 2022 and held it in 8 quarters. The position peaked at $6.31M in Q3 2023. 1,309 funds tracked by Wall St. Rank hold REGN as of Q1 2024.

Power Corp of Canada reported no remaining Regeneron Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
Power Corp of Canada sold 6,078 Regeneron Pharmaceuticals shares in Q1 2024, an estimated $5.34M.
Power Corp of Canada first reported a position in Regeneron Pharmaceuticals in Q1 2022 and held it in 8 quarters.
Power Corp of Canada's Regeneron Pharmaceuticals position peaked at $6.31M in Q3 2023.
1,309 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2024.

Based on Power Corp of Canada's 13F filing for Q1 2024, filed 14 May 2024.